"Designing Growth Strategies is in our DNA"

U.S. Antiepileptic Drugs (AED) Market Size, Share & COVID-19 Impact Analysis, By Drug Generation (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI109143

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Epilepsy, 2022
    2. New Product Launches, Key Players
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Pipeline Analysis
    5. Impact of Covid-19 on the Market
  5. U.S. Antiepileptic Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Generation
      1. First Generation Drugs
      2. Second Generation Drugs
      3. Third Generation Drugs
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. UCB S.A.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. GSK plc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. H. Lundbeck A/S
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Eisai Co., Ltd.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Sanofi
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Sunovion Pharmaceuticals Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Jazz Pharmaceuticals, Inc.
        1. Overview
        2. Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Antiepileptic Drugs Market Revenue Breakdown (USD billion, %), By Drug Generation, 2022 & 2030

Figure 2: U.S. Antiepileptic Drugs Market Value Share (%), By Drug Generation, 2022 & 2030

Figure 3: U.S. Antiepileptic Drugs Market Value Share (%), By Distribution Channel, 2022 & 2030

Table 1: U.S. Antiepileptic Drugs Market Revenue (USD billion) Forecast, By Drug Generation, 2019–2030

Table 2: U.S. Antiepileptic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

U.S. Antiepileptic Drugs (AED) Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 60
Consulting Services
    How will you benefit from our consulting services ?